Innova Captab IPO: Company laps up Rs 171 crore from anchor investors ahead of Thursday’s opening
anchor investors ahead of its initial public offer (IPO), which opens on Thursday. The three-day issue will close on December 26, Tuesday, as markets will remain shut for trading on December 25, Monday, on account of Christmas.
The anchor investors were allotted 3,816,963 shares to 17 investors, which included the likes of ICICI Prudential Pharma Healthcare and Diagnostics (PHD) Fund, Kotak Mahindra Trustee Co Ltd A/C Kotak Healthcare Fund, 360 One Special Opportunities Fund Series-9, Bandhan Smallcap Fund, Aditya Birla Sun Life Company, among others.
As per the filing to the exchanges, six domestic mutual funds have applied through a total of eight schemes, accounting for 44.88% of the anchor investor portion. The amount raised through them is over Rs 76.74 crore, the filing said.
About Innova Captab:
Innova Captab is an integrated pharmaceutical company in India with a presence across the pharmaceutical value chain, including research and development, manufacturing, drug distribution and marketing, and exports.
Innova Captab IPO Structure:
The price band of this public issue is fixed at Rs 426-448, and at the upper end, the company plans to raise Rs 570 crore. Investors can bid for 33 shares in one lot and in multiples thereafter. About 50% of the offer is reserved for qualified institutional buyers, 35% for retail investors, and the remaining 15% for non-institutional investors.
Innova Captab IPO GMP today:
According to market analysts, the current GMP of Innova Captab is Rs 210 in the unlisted market.
Innova Captab IPO Details:
The IPO will be a combination of a fresh issue of equity shares worth up to Rs 400 crore and an offer-for-sale (OFS) of up to 9,600,000 equity shares by the promoter and selling
Read more on economictimes.indiatimes.com
